Baseline blood pressure modifies the role of blood pressure variability in mortality: Results from the ACCORD trial.
作者信息
Nuyujukian Daniel S, Newell Michelle S, Zhou Jin J, Koska Juraj, Reaven Peter D
机构信息
Research Service, Phoenix VA Health Care System, Phoenix, Arizona, USA.
Epidemiology and Biostatistics, University of Arizona, Tucson, Arizona, USA.
出版信息
Diabetes Obes Metab. 2022 May;24(5):951-955. doi: 10.1111/dom.14649. Epub 2022 Jan 24.
Abstract
摘要
相似文献
1
Baseline blood pressure modifies the role of blood pressure variability in mortality: Results from the ACCORD trial.基线血压改变了血压变异性在死亡率中的作用：ACCORD试验结果
Diabetes Obes Metab. 2022 May;24(5):951-955. doi: 10.1111/dom.14649. Epub 2022 Jan 24.
2
Association of Polygenic Risk Score With Blood Pressure and Adverse Cardiovascular Outcomes in Individuals With Type II Diabetes: Insights From the ACCORD Trial.2型糖尿病患者多基因风险评分与血压及不良心血管结局的关联：来自ACCORD试验的见解
Hypertension. 2022 May;79(5):e100-e102. doi: 10.1161/HYPERTENSIONAHA.122.18976. Epub 2022 Apr 4.
3
The Influence of Baseline Diastolic Blood Pressure on the Effects of Intensive Blood Pressure Lowering on Cardiovascular Outcomes and All-Cause Mortality in Type 2 Diabetes.基础舒张压对强化降压对 2 型糖尿病心血管结局和全因死亡率影响的影响。
Diabetes Care. 2020 Aug;43(8):1878-1884. doi: 10.2337/dc19-2047. Epub 2020 May 4.
4
The goal blood pressure in type 2 diabetes: do we have an ACCORD?2型糖尿病的目标血压：我们有“控制糖尿病患者心血管风险行动（ACCORD）”那样的方案吗？
Consult Pharm. 2010 Oct;25(10):686, 688. doi: 10.4140/TCP.n.2010.686.
5
Is there accord in ACCORD? Lower blood pressure targets in type 2 diabetes does not lead to fewer cardiovascular events except for reductions in stroke.“控制糖尿病患者心血管风险行动”（ACCORD）研究结果一致吗？2型糖尿病患者更低的血压目标除了能减少中风外，并不会导致心血管事件减少。
J Clin Hypertens (Greenwich). 2010 Jul 1;12(7):472-7. doi: 10.1111/j.1751-7176.2010.00333.x.
6
Pharmacotherapy: ACCORD Blood Pressure and ACCORD Lipid: how low can we go?药物治疗：控制糖尿病患者心血管风险行动（ACCORD）血压研究和ACCORD血脂研究：我们能降至多低？
Nat Rev Endocrinol. 2010 Sep;6(9):483-4. doi: 10.1038/nrendo.2010.128.
7
Generalizability and effect size of the impact of uncontrolled hypertension in patients with type 2 diabetes mellitus.2型糖尿病患者中未控制高血压影响的可推广性及效应量
J Clin Hypertens (Greenwich). 2022 May;24(5):660-661. doi: 10.1111/jch.14471. Epub 2022 Mar 21.
8
Longer time in blood pressure target range improves cardiovascular outcomes among patients with Type 2 diabetes: A secondary analysis of a randomized clinical trial.2型糖尿病患者在血压目标范围内停留时间更长可改善心血管结局：一项随机临床试验的二次分析
Diabetes Res Clin Pract. 2023 Apr;198:110600. doi: 10.1016/j.diabres.2023.110600. Epub 2023 Feb 27.
9
Drug treatment for hypertensive patients in special situations: diabetes and hypertension.特殊情况下高血压患者的药物治疗：糖尿病与高血压
Clin Exp Hypertens. 1999 Jul-Aug;21(5-6):895-906. doi: 10.3109/10641969909061018.
10
Blood pressure control in type 2 diabetes.
N Engl J Med. 2010 Aug 12;363(7):696-7; author reply 697. doi: 10.1056/NEJMc1006411.
引用本文的文献
1
Provisional Decision-Making for Perioperative Blood Pressure Management: A Narrative Review.围手术期血压管理的临时决策：叙事性综述。
Oxid Med Cell Longev. 2022 Jul 11;2022:5916040. doi: 10.1155/2022/5916040. eCollection 2022.
本文引用的文献
1
Refining determinants of associations of visit-to-visit blood pressure variability with cardiovascular risk: results from the Action to Control Cardiovascular Risk in Diabetes Trial.精细化研究血压变异性与心血管风险关联的决定因素：来自行动研究控制糖尿病心血管风险试验的结果。
J Hypertens. 2021 Nov 1;39(11):2173-2182. doi: 10.1097/HJH.0000000000002931.
2
New Insights into the Role of Visit-to-Visit Glycemic Variability and Blood Pressure Variability in Cardiovascular Disease Risk.浅析血糖波动和血压波动在心血管疾病风险中的作用
Curr Cardiol Rep. 2021 Mar 2;23(4):25. doi: 10.1007/s11886-021-01454-x.
3
Blood Pressure Variability and Risk of Heart Failure in ACCORD and the VADT.血压变异性与 ACCORD 和 VADT 中的心力衰竭风险。
Diabetes Care. 2020 Jul;43(7):1471-1478. doi: 10.2337/dc19-2540. Epub 2020 Apr 23.
4
Association between blood pressure variability, cardiovascular disease and mortality in type 2 diabetes: A systematic review and meta-analysis.血压变异性与 2 型糖尿病患者心血管疾病和死亡的关系：系统评价和荟萃分析。
Diabetes Obes Metab. 2019 Dec;21(12):2587-2598. doi: 10.1111/dom.13828. Epub 2019 Aug 9.
5
Visit-to-visit Blood Pressure Variability and Arterial Stiffness: Which Came First: The Chicken or the Egg?血压变异性与动脉僵硬度：孰因孰果？
Curr Pharm Des. 2019;25(6):685-692. doi: 10.2174/1381612825666190329122024.
6
Glycemic Variation and Cardiovascular Risk in the Veterans Affairs Diabetes Trial.血糖波动与退伍军人事务部糖尿病试验中的心血管风险。
Diabetes Care. 2018 Oct;41(10):2187-2194. doi: 10.2337/dc18-0548. Epub 2018 Aug 6.
7
Blood pressure variability and risk of cardiovascular events and death in patients with hypertension and different baseline risks.血压变异性与不同基线风险的高血压患者心血管事件和死亡风险。
Eur Heart J. 2018 Jun 21;39(24):2243-2251. doi: 10.1093/eurheartj/ehx760.
8
Diabetes and Hypertension: A Position Statement by the American Diabetes Association.糖尿病与高血压：美国糖尿病协会的立场声明
Diabetes Care. 2017 Sep;40(9):1273-1284. doi: 10.2337/dci17-0026.
9
Visit-to-visit variability of blood pressure and cardiovascular outcomes in patients with stable coronary heart disease. Insights from the STABILITY trial.稳定性冠心病患者的血压变异性与心血管结局。来自 STABILITY 试验的观察。
Eur Heart J. 2017 Oct 1;38(37):2813-2822. doi: 10.1093/eurheartj/ehx250.
10
Diastolic Blood Pressure, Subclinical Myocardial Damage, and Cardiac Events: Implications for Blood Pressure Control.舒张压、亚临床心肌损伤与心脏事件：对血压控制的启示
J Am Coll Cardiol. 2016 Oct 18;68(16):1713-1722. doi: 10.1016/j.jacc.2016.07.754. Epub 2016 Aug 30.
Zotero 插件